drugset / Trial / NCT06926491
Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）
NaSingle-groupOpen-labelTreatment
Summary
This trial will evaluate the efficacy of KK8398 on annualized height velocity after 52 weeks of repeated administration of KK8398 to patients with achondroplasia
Timeline
- Start
- 2024-12-01
- Primary completion
- 2029-05-31
- Completion
- 2031-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KK8398 | Unknown | — | — |